Dr Reddy’s Labs net profit doubles in Q1: What should investors do?

July 29, 2022

Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well as, pressure on operating performance as key drags. Despite near-term headwinds, most brokerage firms maintained their rating and target prices but slashed earnings per share (EPS) estimates for FY23-24.

More To Explore

NSE, former chief Vikram Limaye, others settled TAP system case with Sebi; pay Rs 643 cr

The National Stock Exchange (NSE), its former chief Vikram Limaye and eight others on Friday settled with markets regulator Sebi a case pertaining to alleged

October 4, 2024

Tech View: Nifty breaks below 50 DEMA, forms bear candle. How to trade on Monday

A bear candle appeared on both the daily and weekly charts, indicating a sharp reversal in Nifty’s near-term uptrend. Currently positioned near the support level

October 4, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003